Thalia Salinas

Thalia Salinas practices at NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital.

Thalia Salinas' NPI, 1255718136, was assigned on April 30, 2015. Thalia Salinas graduated from Baylor College Of Medicine in 2015. Thalia Salinas holds New York license 305474.

Thalia Salinas' primary practice is NewYork-Presbyterian/Weill Cornell Medical Center, at 525 East 68th Street, New York, NY 10065 in New York County. The practice phone is (212) 746-5454.

Thalia Salinas' primary practice is NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital. The medical group on file is Weill Cornell Physicians. Dmand AI also links Thalia Salinas to 2 more clinical labs and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Thalia Salinas practices, 3 sites in all. Vendor and product names are available with a free account.

Nephrology is Thalia Salinas' primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Thalia Salinas is board certified in internal medicine by the American Board of Internal Medicine. Thalia Salinas is licensed in New York.

Dmand AI lists chronic anemia, chronic hypertension, chronic kidney disease and immune deficiency disease among the conditions Thalia Salinas treats.

CMS data shows 706 Medicare services from Thalia Salinas across 4 procedure codes in 2024, for 148 Medicare patients. Medicare paid $61,657 for them.

CMS counts 148 Medicare patients who saw Thalia Salinas in 2024. The largest group is under 65, with 67 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 39% are also on Medicaid. Their average risk score is 6.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Thalia Salinas' median patient age at 64, with 40% women.

In 2024, Thalia Salinas wrote 444 Medicare Part D claims for 97 patients. 84% of them were for generic drugs. CMS names the drug for 220 of them, across 13 drugs with 11 or more claims each, at $34,927 in total drug cost. In 2023, CMS named 257 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Thalia Salinas for performance year 2024, reported through an alternative payment model (APM). Thalia Salinas accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Thalia Salinas as offering telehealth.

Dmand AI links 16 papers to Thalia Salinas, published from 2020 to 2024. 2020 was the busiest year, with 4. The most frequent topics are Kidney Transplantation, Graft Rejection and Allografts. Thalia Salinas has published most often in J Immunol Methods. Thalia Salinas' most frequent co-authors are Manikkam Suthanthiran, MD, Darshana M. Dadhania, MD and Vijay Kumar Sharma, MD.

CMS Open Payments shows 3 general payments to Thalia Salinas from 3 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. Eli Lilly and Company paid the most, $24.

Dmand AI lists 1 award for Thalia Salinas.

Thalia Salinas graduated from Baylor College Of Medicine in 2015.